MedTrace Logo

Use of Aromatase Inhibitor Before Misoprostol in Medical Termination of Miscarriage

NCT07109947 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-08-07

No results posted yet for this study

Summary

Abortion is one of the most common complications of pregnancy. Missed abortion is a type of abortions, occurs in 15%-20% of clinically diagnosed pregnancies and is defined as the retention of pregnancy products in the uterus for several days or weeks after death of the fetus.

Conditions

  • Miscarriage

Interventions

DRUG

Letrozole 2.5mg

to determine the effect of Letrozole as a premedication before misoprostol treatment used to induce missed miscarriage.

Sponsors & Collaborators

  • Aswan University

    lead OTHER

Principal Investigators

  • Hani Ahmed Farouk, Assist.Prof. · Obstetrics and Gynecology,Faculty of Medicine,Aswan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-10
Primary Completion
2025-12-01
Completion
2025-12-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07109947 on ClinicalTrials.gov